IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

23 hedge funds and large institutions have $601K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$108K
2
+$99K
3
+$94K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$20K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17K

Top Sellers

1
-$8K
2
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$256K
2
$99K
3
$94K
4
$58K
5
$22K
6
$20K
7
$17K
8
$10K
9
$10K
10
$8K
11
$7K
12
$1
13
$1
14
–
15
–